期刊文献+

早期乳腺癌腋窝前哨淋巴结阳性患者腋窝非前哨淋巴结转移风险预测 被引量:12

Predicting the risk of non-sentinel lymph node metastasis in breast cancer patients with 1-2 positive sentinel lymph nodes
原文传递
导出
摘要 目的分析前哨淋巴结活检(SLINB)1~2个阳性乳腺癌患者中非前哨淋巴结(NSLN)转移的影响因素并构建预测模型:方法冋顾分析2008-2014年中国医学科学院北京协和医学院肿瘤医院未行新辅助化疗前哨淋巴结1?2个阳性并行腋窝淋巴结清扫的乳腺癌患者的临床病理因素。计数资料组间比较采用X2检验,多因素分析采用x^2回归模型。以AUC值和校正曲线对Nomogram预测模型进行评估。结果共270例患者纳入研究,87例(32.2%)存在NSLN转移,中位年龄46(21~80)岁,中位SLN送检个数4(1~10)个,中位腋窝淋巴结清扫个数20(10~41)个。单因素分析结果显示病理分级、SLN宏转移、阳性SLN个数和阴性SLN个数是腋窝NSLN转移的影响因素(P=0.001~0.045)。多因素分析结果显示病理分级、阳性SLN个数和阴性SLN个数是NSLN转移的独立影响因素(P=0.000~0.041)。乳腺癌NSLN转移Nomogram预测模型AUC=0.70,当预测患者的NSLN转移率≤15%时,假阴性率仅为10.57“结论Nomogram预测模型可作为临床医师进行腋窝处理时的决策参考,对于NSLN转移概率低的患者可以避免行腋窝淋巴结清扫或腋窝放疗。 Objective To evaluate the risk factors of non-sentinel lymph node(NSLN)metastasis in breast c*ancer patients with 1-2 positive sentinel lymph nodes and to establish a new Nomogram prediction model.Methods Clinicopathological data of breast cancer patients who were diagnosed with 1-2 positiv.e lymph nodes and underw-ent axillary lymph node dissection(ALND)without neoadjuvant chemotherapy from January 2008 to December 2014 were retrospectively analyzed.Measurement data between two groups were analyzed by chi-square test.Multivariate analysis was performed by logistic regression model.The prediction accuracy of the Nomogram model was evaluated using the area under the receiver operating characteristic curve(AUC)and calibration curves.Results A total of 270 patients were recruited in this study.Among them.87(32.2%)patients had NSLN metastases.The median age was 46 years old(21-80 yars),the median number of SLNs was 4(1-10)ami the median number of axillary lymph nodes was 20(10-41).Univariate analysis demonstrated that the pathological grade,the size of SLN metastasis,the number of negative and positive SLNs were the risk factors of NSLN metastasis(P=0.00l-0.045).Multivariate analysis showed that pathological grade,the number of negative and positive SLNs were independent risk factors of NSLN metastasis(P=0.000-0.041).The AUC value of Nomogram prediction model for NSLN metastasis was 0.70.The false negative rate of Nomogram was 10.5%when the cut-off point of predictive probability was≤15%.Conclusions The Nomogram is a useful prediction model for evaluating NSLN metastasis.ALND or axillary radiotherapy can be avoided for patients with a low probability of NSLN metastasis.
作者 黄州 唐玉 王淑莲 宋永文 金晶 房辉 张江鹄 景灏 王健仰 刘跃平 陈波 亓姝楠 李宁 唐源 卢宁宁 李晔雄 Huang Zhou;Tang Yu;Wang Shulian;Song Yongwen;Jin Jing;Fang Hui;Zhang Jianghu;Jing Hao;Wang Jianyang;Liu Yueping;Chen Bo;Qi Shunan;Li Ning;Tang Yuan;Lu Ningning;Li Yexiong(Department of Radiation Oncology,National Cancer Center/Cancer Hospital,Chinese Academy of Medical Sciences(CAMS)and Peking Union Medical College(PUIUC).Beijing 100021.China)
出处 《中华放射肿瘤学杂志》 CSCD 北大核心 2019年第2期102-107,共6页 Chinese Journal of Radiation Oncology
基金 国家重点研发计划项目(2016YFC0904600).
关键词 乳腺肿瘤 前哨淋巴结 非前哨淋巴结 预测模型 Breast neoplasms Sentinel lymph node Non-sentinel lymph node Prediction model
作者简介 通信作者:宋永文,Email:song21yongwen@aliyun.com;通信作者:李晔雄,Email:yexiongl2@163.com
  • 相关文献

参考文献3

二级参考文献17

  • 1Veronesi U, Paganelli G, Viale G, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer[ J]. N Engl J Med, 2003,349:546-553.
  • 2Fleissig A, Fallowfield LJ, Langridge CI, et al. Post-operative ann morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer[ J]. Breast Cancer Res Treat,2006, 95:279-293.
  • 3Krag DN, Anderson SJ, Julian TB, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial[ J ]. Lancet Oncol, 2010,11:927-933.
  • 4Giuliano AE, Morrow M, Duggal S, et al. Should ACOSOG Z0011 change practice with respect to axillary lymph node dissection for a positive sentinel lymph node biopsy in breast cancer[ J] ? Clin Exp Metastasis,2012,29:687-692.
  • 5Galimberti V, Cole BF,Zurrida S, et al. Axillary dissection versus axillary dissection in patients with sentinel-node micrometastases ( IBCSG 23-01 ) : a phase 3 randomised controlled trial[ J]. Lancet Oncol,2013,14:297-305.
  • 6Coutant C, Olivier C, Lambaudie E, et al. Comparison of models to predict nonsentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: a prospective muhicenter study[J]. J Clin Oncol, 2009,27:2800-2808.
  • 7Van Zee KJ, Manasseh DM, Bevilacqua JL, et al. A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy[J]. Ann Surg 0ncol,2003,10 : 1140-1151.
  • 8Degnim AC, Reynolds C, Pantvaidya G, et al. Nonsentinel node metastasis in breast cancer patients: assessment of an existing and a new predictive nomogram[ J]. Am J Surg,2005,190:543-550.
  • 9Pal A, Provenzano E, Duffy SW, et al. A model for predicting non-sentinel lymph node metastatic disease when the sentinel lymph node is positiv[ J]. Br J Surg,2008,95:302-309.
  • 10Barranger E, Coutant C, Flahauh A, et al. An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement [ J ]. Breast Cancer Res Treat,2005,91:113-119.

共引文献1074

同被引文献85

引证文献12

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部